PropThink: Reason To Own STJ Is Gone; Pressure Remains On The Stock

[ACN Newswire] – By David MoskowitzShares of St. Jude Medical (NYSE:STJ) fell Thursday after the company announced negative results from the RESPECT trial, which was expected to support U.S. approval of the Amplatzer PFO … more

View todays social media effects on STJ

View the latest stocks trending across Twitter. Click to view dashboard